Purchase Report

$1200SINGLE USER LICENSE$1500TEAM LICENSE$2500CORPORATE LICENSE

DESCRIPTION

TABLE OF CONTENTS

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Colombia is the third largest country in Latin America with a very good education system and literacy rate. It has huge petroleum reserves and mineral sources, which contribute to its high GDP. The presidential republic government is a stable one as compared to other Latin American countries. The country has a seen a consistent growth in the last two decades and is the best country in Latin America for ease of doing business. It also has many trade agreements with the EU and is located at strategically with modern port facilities, which provide the country access to major markets, help in the rapid expansion of extractive industries, lower the unemployment rate, and kept the inflation in check.

The government has 13 trade agreements in force with CAN, Mercosur, Caricom, G3, EFTA, US-Colombia Trade Agreements and is currently negotiating 8 more. The country has been facing challenges like corruption, terrorism, and poor infrastructure. The difficult geography and poor transport infrastructure are not helping the government either but haven’t slowed down development.

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

1.1 Scope of the Report

1.2 Regional Analysis

1.2.1 PESTLE Analysis

1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

2.1 Drivers

2.2 Restraints

2.3 Opportunities

3. Market Demand Analysis

3.1 Socio-Economic Segmentation

3.2 Demographic Strengths & Weaknesses

3.3 Spending Patterns

3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

4.1 By Types of Inorganic Compounds

4.2 By Bacterial Products

5. Market Entry

5.1 Market Entry: The Strategy

5.1.1 Types of Entry Modes, by Market Entry Objectives

5.1.2 Competition Analysis

5.1.2.1 Market Share

5.1.2.2 Strategies Adopted, Recent Events

5.1.3 Pricing Strategy

5.1.4 Supply Chain Analysis

5.1.4.1 Trade (Import-Export Analysis)

5.1.4.2 Distribution Network & Retail Analysis

5.2 Market Entry: The Administration

5.2.1 How to Register a Company (Flowchart)

5.2.2 Registration Processes

5.2.2.1 Ministries Involved

5.2.2.2 Criteria and Conditions

5.2.3 List of Forms & Documents

5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Purchase Report

$1200SINGLE USER LICENSE

Only a single designated user can access the report.

Delivered in pdf format in 24 to 72 hours of purchase.

Comes with

3

months of post-purchase analyst support.

$1500TEAM LICENSE

Up to 7 users can access the report.

Delivered in pdf format in 24 to 72 hours of purchase.

Comes with

3

months of post-purchase analyst support.

$2500CORPORATE LICENSE

Any employee of your organization or its subsidiaries can access the report.